Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.
Not Applicable
- Conditions
- cerebral infarction
- Registration Number
- JPRN-UMIN000010477
- Lead Sponsor
- Department of Neurology, Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)extensive cerebral infarction(more than one third of the middle cerebral artery territory) 2)severe dysphagia 3)hepatic function disorder (Child-Pugh B or C) 4)renal dysfunction (CCr<30ml/min) 5)anemia (Hb<10.0g/dl) 6)hemorrhagic event
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method early recurrent stroke within 14 days, all embolism within 14 days except ischemic stroke, all strokes within 14 days, all hemorrhagic event within 14 days
- Secondary Outcome Measures
Name Time Method